First Horizon Advisors, Inc. Recursion Pharmaceuticals, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.28 Billion
- Q2 2024
A detailed history of First Horizon Advisors, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 6,901 shares of RXRX stock, worth $59,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,901
Previous 6,194
11.41%
Holding current value
$59,210
Previous $61,000
16.39%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
270Shares Held
193MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$211 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$207 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$137 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$106 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V711.9MShares$102 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.55B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...